Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Lapalombella

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Blood|July 30, 2016
Two strikes against CLLRosa Lapalombella
Blood|October 7, 2017
Mitochondria on the move: BMSCs fuel AML energyRosa Lapalombella
Blood|August 8, 2015
Interleukin-6 in CLL: accelerator or brake?Rosa Lapalombella
Leukemia & Lymphoma|June 16, 2020
Selinexor for advanced hematologic malignanciesJanek S Walker, Ramiro Garzon, Rosa Lapalombella
BMC Cell Biology|January 28, 2006
Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric studyFrancesco Fabbri, Silvia Carloni, Giovanni Brigliadori, et al.
Blood|July 9, 2010
The clinical application of monoclonal antibodies in chronic lymphocytic leukemiaSamantha M Jaglowski, Lapo Alinari, Rosa Lapalombella, et al.
Experimental Hematology & Oncology|October 30, 2021
Red blood cells differentiated in vitro using sequential liquid and semi-solid culture as a pre-clinical modelMatthew Cannon, Hannah Phillips, Sidney Smith, et al.
Neurological Research|April 10, 2008
Persistence of regenerative myogenesis in spite of down-regulation of activity-dependent genes in long-term denervated rat muscleRosa Lapalombella, Helmut Kern, Nicoletta Adami, et al.
Leukemia & Lymphoma|January 9, 2010
Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemiaFarrukh T Awan, Amy J Johnson, Rosa Lapalombella, et al.
Journal of Hematology & Oncology|June 30, 2021
Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylationShaneice Mitchell, Pu Zhang, Matthew Cannon, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Blood|July 30, 2016
Two strikes against CLLRosa Lapalombella
Blood|October 7, 2017
Mitochondria on the move: BMSCs fuel AML energyRosa Lapalombella
Blood|August 8, 2015
Interleukin-6 in CLL: accelerator or brake?Rosa Lapalombella
Leukemia & Lymphoma|June 16, 2020
Selinexor for advanced hematologic malignanciesJanek S Walker, Ramiro Garzon, Rosa Lapalombella
BMC Cell Biology|January 28, 2006
Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric studyFrancesco Fabbri, Silvia Carloni, Giovanni Brigliadori, et al.
Blood|July 9, 2010
The clinical application of monoclonal antibodies in chronic lymphocytic leukemiaSamantha M Jaglowski, Lapo Alinari, Rosa Lapalombella, et al.
Experimental Hematology & Oncology|October 30, 2021
Red blood cells differentiated in vitro using sequential liquid and semi-solid culture as a pre-clinical modelMatthew Cannon, Hannah Phillips, Sidney Smith, et al.
Neurological Research|April 10, 2008
Persistence of regenerative myogenesis in spite of down-regulation of activity-dependent genes in long-term denervated rat muscleRosa Lapalombella, Helmut Kern, Nicoletta Adami, et al.
Leukemia & Lymphoma|January 9, 2010
Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemiaFarrukh T Awan, Amy J Johnson, Rosa Lapalombella, et al.
Journal of Hematology & Oncology|June 30, 2021
Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylationShaneice Mitchell, Pu Zhang, Matthew Cannon, et al.
Pageof 9